METOJECT 27.5 mg/0.55 ml, solution for injection in a pre-filled pen pen, 0.55 ml
Active ingredients: Methotrexate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 0.55 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METOJECT 27,5 mg/0,55 ml, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 stylo prérempli de 0,55 ml avec seringue(s) en verre avec aiguille(s)
- Marketing authorisation holder
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Oct 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66418655CIP73002049CIP133400930020494Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOTREXATEsolution | 27,5 mg · un stylo prérempli de 0,55 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.